<div id="readability-page-1"><div><div>                                                                                                                                                <div><p>Momentum traders who seek fast-moving stocks have three to look at.</p><p> Sandisk (SNDK) gained 15.2% in the last week. It trades at the top end of its $200 - $240 trading range that began in mid-November. Technology investors are betting that the severe shortage of NAND, used for storage, and DRAM, used in memory, will lift Sandisk’s profit margins.</p></div><p>Sandisk benefits from the historic upcycle for DRAM and NAND TLC spot prices. PC makers, for example, had to pay around 300% more for memory modules in October and November.</p><div><p>In the vaccine market, Moderna (MRNA) continued its breakout to close at $33.80, up by 9.2% on December 19. The Coalition for Epidemic Preparedness Innovations (CEPI), which is a global partnership supporting vaccine studies, will invest up to $54.3 million in Moderna’s study. The firm has an experimental bird flu shot in Phase 3 pivotal trials.</p><p> MRNA stock trades as if a buyer might consider bidding for the firm.</p></div><p>Carnival (CCL) jumped by 9.81% last Friday to close at $31.12. The cruise ship firm posted occupancy rates of 102%, while passengers carried fell by 13% Q/Q. The onboard spending and close-in demand are accelerating. In 2026, the firm expects the positive momentum to continue.</p><p>Carnival benefits from revenue managers creating strong brand awareness, which increases ship booking volumes.<br/></p></div></div></div>

MRNA

SNDK

<p>Sandisk, Moderna, and Carnival stocks have recently soared. Sandisk gained 15.2% due to a NAND and DRAM shortage, boosting profit margins. Moderna rose 9.2% with CEPI investing $54.3 million in its vaccine study, and potential acquisition interest. Carnival increased 9.81% with high occupancy rates and strong onboard spending, expecting continued momentum in 2026.</p>

What to do After Sandisk, Moderna, and Carnival Soared